title: Ablative therapy supported by autologous bone marrow transplantation with in vitro treatment of marrow in patients with B-cell malignancy.
authors.affiliation: ICRF Department of Medical Oncology, St. Bartholomew's Hospital, London, UK.
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: S
authors.initials: S
authors.lastname: Arnott
authors.forename: N
authors.initials: N
authors.lastname: Plowman
authors.forename: F
authors.initials: F
authors.lastname: Cotter
authors.forename: K
authors.initials: K
authors.lastname: Adams
authors.forename: E L
authors.initials: EL
authors.lastname: Batten
authors.forename: S
authors.initials: S
authors.lastname: Outram
authors.forename: J A
authors.initials: JA
authors.lastname: Amess
authors.forename: M A
authors.initials: MA
authors.lastname: Horton
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000276:immunology*; D001853:Bone Marrow / Q000276:immunology*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D066298:In Vitro Techniques; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D014182:Transplantation, Autologous
chemical_list: D000961:Antilymphocyte Serum